Parallax Volatility Advisers’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,000
Closed -$4.91M 1636
2025
Q4
$4.91M Buy
40,000
+30,000
+300% +$3.65M 0.01% 678
2025
Q3
$1.11M Sell
10,000
-67,800
-87% -$7.71M ﹤0.01% 1077
2025
Q2
$8.63M Buy
77,800
+27,800
+56% +$2.96M 0.02% 473
2025
Q1
$5.6M Sell
50,000
-258,700
-84% -$26.7M 0.02% 592
2024
Q4
$28.5M Buy
308,700
+241,700
+361% +$21.8M 0.06% 279
2024
Q3
$5.62M Sell
67,000
-470,100
-88% -$35.9M 0.01% 747
2024
Q2
$36.9M Buy
537,100
+360,700
+204% +$24.1M 0.08% 187
2024
Q1
$12.9M Buy
176,400
+60,800
+53% +$4.68M 0.03% 438
2023
Q4
$9.36M Sell
115,600
-191,800
-62% -$14.9M 0.02% 608
2023
Q3
$23M Buy
307,400
+288,600
+1,535% +$22.2M 0.05% 288
2023
Q2
$1.45M Sell
18,800
-104,200
-85% -$8.31M ﹤0.01% 1255
2023
Q1
$10.2M Sell
123,000
-147,200
-54% -$12.2M 0.02% 579
2022
Q4
$23.2M Buy
270,200
+25,900
+11% +$2.05M 0.04% 479
2022
Q3
$15.1M Sell
244,300
-85,300
-26% -$5.38M 0.02% 624
2022
Q2
$20.4M Buy
329,600
+298,600
+963% +$18.5M 0.02% 482
2022
Q1
$1.84M Sell
31,000
-656,000
-95% -$41.9M ﹤0.01% 1392
2021
Q4
$49.9M Buy
687,000
+686,000
+68,600% +$47.2M 0.06% 230
2021
Q3
$70K Buy
+1,000
New +$70.3K ﹤0.01% 1798
2021
Q1
Sell
-605,300
Closed -$35.3M 1416
2020
Q4
$35.3M Sell
605,300
-127,200
-17% -$7.68M 0.04% 385
2020
Q3
$46.3M Buy
732,500
+86,000
+13% +$5.96M 0.03% 420
2020
Q2
$49.7M Buy
646,500
+166,600
+35% +$12.8M 0.06% 267
2020
Q1
$35.9M Sell
479,900
-41,200
-8% -$2.85M 0.05% 256
2019
Q4
$33.9M Buy
521,100
+318,800
+158% +$20.8M 0.04% 289
2019
Q3
$12.8M Sell
202,300
-412,100
-67% -$26.9M 0.01% 523
2019
Q2
$41.5M Buy
614,400
+444,000
+261% +$29.2M 0.05% 206
2019
Q1
$11.1M Sell
170,400
-189,400
-53% -$12.6M 0.01% 454
2018
Q4
$22.5M Sell
359,800
-82,800
-19% -$5.79M 0.03% 321
2018
Q3
$34.2M Sell
442,600
-55,200
-11% -$4.17M 0.04% 192
2018
Q2
$35.3M Buy
497,800
+40,100
+9% +$2.83M 0.05% 168
2018
Q1
$34.5M Sell
457,700
-331,400
-42% -$26.3M 0.05% 164
2017
Q4
$56.5M Buy
789,100
+295,000
+60% +$22.4M 0.08% 121
2017
Q3
$40M Sell
494,100
-169,100
-25% -$12.9M 0.07% 156
2017
Q2
$46.9M Buy
663,200
+590,700
+815% +$39.3M 0.09% 133
2017
Q1
$4.92M Sell
72,500
-300
-0.4% -$21.1K 0.01% 588
2016
Q4
$5.21M Sell
72,800
-22,500
-24% -$1.67M 0.01% 631
2016
Q3
$7.54M Buy
95,300
+60,000
+170% +$4.87M 0.01% 542
2016
Q2
$2.94M Sell
35,300
-79,300
-69% -$7.04M 0.01% 796
2016
Q1
$10.5M Sell
114,600
-782,200
-87% -$70.5M 0.02% 354
2015
Q4
$90.7M Buy
896,800
+181,900
+25% +$18.9M 0.18% 70
2015
Q3
$70.2M Buy
714,900
+65,200
+10% +$7.24M 0.16% 97
2015
Q2
$76.1M Sell
649,700
-712,000
-52% -$77.8M 0.16% 80
2015
Q1
$134M Buy
1,361,700
+45,100
+3% +$4.58M 0.32% 42
2014
Q4
$124M Buy
1,316,600
+672,700
+104% +$69.6M 0.36% 51
2014
Q3
$68.5M Buy
643,900
+63,300
+11% +$6.2M 0.22% 93
2014
Q2
$48.1M Buy
580,600
+96,600
+20% +$7.52M 0.2% 85
2014
Q1
$34.3M Sell
484,000
-913,400
-65% -$71.6M 0.2% 105
2013
Q4
$105M Buy
1,397,400
+75,700
+6% +$5.27M 0.51% 39
2013
Q3
$83.1M Sell
1,321,700
-70,400
-5% -$4.21M 0.44% 45
2013
Q2
$71.4M Buy
+1,392,100
New +$72.6M 0.33% 59

Other funds holding GILD

Parallax Volatility Advisers's GILD Position: Q1 2026 in Review

Parallax Volatility Advisers increased its Gilead Sciences (GILD) stake by 3,738% in Q1 2026, buying an estimated $1.84M and bringing the position to 13,470 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #817.

Parallax Volatility Advisers first reported a position in GILD in Q3 2013 and has held it in 38 quarters since. The position peaked at $36.8M in Q4 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Parallax Volatility Advisers held 13,470 shares of Gilead Sciences worth $1.8M as of Q1 2026.
  • Parallax Volatility Advisers bought 13,119 Gilead Sciences shares in Q1 2026, an estimated $1.84M.
  • Gilead Sciences made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #817 holding.
  • Parallax Volatility Advisers first reported a position in Gilead Sciences in Q3 2013 and has held it in 38 quarters since.
  • Parallax Volatility Advisers's Gilead Sciences position peaked at $36.8M in Q4 2014.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.